BioVentrix

United States · Healthtech

BioVentrix develops medical devices for cardiac remodeling in patients with heart failure caused by damage to the left ventricle.

Product

Its Revivent System is designed to reshape the damaged left ventricle through a less invasive procedure. The company is headquartered in Mansfield, Massachusetts.

Clinical development

The RELIVE randomized trial compares the Revivent procedure plus guideline directed medical therapy with medical therapy alone. Revivent remains investigational in the United States.

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Debt and warrant offering$1.2MParticipants not disclosed
Sourcesbioventrix.com ↗